Bepotastine
Bepotastine
Bepotastine (pronunciation: be-po-tas-tine) is a second generation antihistamine intended for the management of allergies. It was approved by the FDA in September 2009.
Etymology
The term "Bepotastine" is derived from its chemical name, which is (S)-4-(4-((4-chlorophenyl)(2-pyridyl)methoxy)piperidino) butyric acid. The prefix "Be-" is derived from "butyric acid", "-pota-" from "piperidino", and "-stine" from "antihistamine".
Usage
Bepotastine is used for the treatment of pruritus (itching) associated with dermatitis and urticaria (hives), and for the treatment of rhinitis (inflammation of the nasal passages). It is also used in eye drop form for the treatment of ocular itching associated with allergic conjunctivitis.
Mechanism of Action
Bepotastine works by blocking the action of histamine, a substance in the body that causes allergic symptoms. It is a highly selective histamine H1 receptor antagonist.
Related Terms
External links
- Medical encyclopedia article on Bepotastine
- Wikipedia's article - Bepotastine
This WikiMD article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski